VK-0214 is an agonist of the thyroid beta receptor (TRbeta). By activating the expression of ABCD2, it can reduce the accumulation of very long-chain fatty acids (VLCFAs) and further alleviate glioblastoma multiforme. VK-0214 has the effect of regulating fatty acid metabolism and can be used in the research of X-linked adrenoleukodystrophy (X-ALD)[1].
Molecular Weight:
412.42
Purity:
99.87
CAS Number:
[852949-30-5]
Formula:
C23H25O5P
Target:
Thyroid Hormone Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted